Related references
Note: Only part of the references are listed.HIV-1 Vaccine Development After STEP
Dan H. Barouch et al.
ANNUAL REVIEW OF MEDICINE (2010)
HLA-Associated Immune Pressure on Gag Protein in CRF01_AE-Infected Individuals and Its Association with Plasma Viral Load
Goragoch Gesprasert et al.
PLOS ONE (2010)
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells
Godwin Nchinda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands
Claudius Grossmann et al.
BMC IMMUNOLOGY (2009)
Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses
Elena Carnero et al.
JOURNAL OF VIROLOGY (2009)
HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
Toshiyuki Miura et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
Godwin Nchinda et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Replicating and non-replicating viral vectors for vaccine development
Marjorie Robert-Guroff
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Immunization of primates with a newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus
Joshua M. DiNapoli et al.
JOURNAL OF VIROLOGY (2007)
A whole-genome association study of major determinants for host control of HIV-1
Jacques Fellay et al.
SCIENCE (2007)
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120 - Negative results fail to trigger a phase 3 correlates trial
Nina D. Russell et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes
Leonia Bozzacco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1
Tong-Ming Fu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela et al.
NATURE MEDICINE (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Engineered viral vaccine constructs with dual specificity:: Avian influenza and Newcastle disease
Man-Seong Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Functional signatures of protective antiviral T-cell immunity in human virus infections
Alexandre Harari et al.
IMMUNOLOGICAL REVIEWS (2006)
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates
A Bukreyev et al.
JOURNAL OF VIROLOGY (2005)
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction
A Granelli-Piperno et al.
JOURNAL OF IMMUNOLOGY (2005)
Single chain antibody fragments for the selective targeting of antigens to dendritic cells
C Demangel et al.
MOLECULAR IMMUNOLOGY (2005)
Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors
Y Nakaya et al.
JOURNAL OF VIROLOGY (2004)
Recombinant Newcastle disease virus as a vaccine vector
T Nakaya et al.
JOURNAL OF VIROLOGY (2001)
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
XJ Gao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals
BPH Peeters et al.
VACCINE (2001)
The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments
K Mahnke et al.
JOURNAL OF CELL BIOLOGY (2000)
Newcastle disease and other avian paramyxoviruses
DJ Alexander
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2000)
Share Paper
